Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

No-deal risk recedes, but new Brexit delay adds to uncertainty

Delay means industry must sustain no-deal investment

Vertex: a vision of treating all CF patients worldwide draws closer

Its high prices are controversial, but Vertex also embodies the best of biopharma drug development

- PMLiVE

Galderma launches Rosacea awareness campaign

Campaign comes on the back of Rosacea Awareness Month

- PMLiVE

Sanofi joins Lilly in insulin price cut, but lawmakers have lost patience

Insulin price nearly tripled between 2002 and 2013

- PMLiVE

Voice biomarker device could diagnose depression, heart disease

Sonde Health raises $16m in series A round

- PMLiVE

Gyroscope advances gene therapy platform, merges with Orbit

News mirrors Ocugen and Histogenics merger

- PMLiVE

NICE says no to Novartis’ Kisqali combo in breast cancer

Double blow after Lilly rival recommended

- PMLiVE

PMEA names Dr Paul Stuart-Kregor as Chair of Judges

He succeeds Professor Brian Smith

The Orkambi row explained

Q&A and timeline

The playbook of a ‘reluctant creative’

Are we all capable of being creative?

Bedrock Healthcare Communications

- PMLiVE

Lynparza set for further expansion with EU approval in breast cancer

Companies have prostate cancer and pancreatic cancer in their sights

- PMLiVE

Brexit causing ‘significant’ generic drug shortages

Generics firms contest reason for shortages

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links